Obesity has reached global epidemic proportions in both adults and children and is
associated with numerous comorbidities, including hypertension (HTN), type II diabetes …

It is important that the medical profession play a significant role in critically evaluating the
use of diagnostic procedures and therapies as they are introduced and tested in the …

Late-breaking clinical trials presented at the 2005, 2006, and 2007 annual scientific
meetings of the ACCF, AHA, and European Society of Cardiology, as well as selected other …

Heart failure (HF) is a major and growing public health problem in the United States.
Approximately 5 million patients in this country have HF, and over 550 000 patients are …

Obesity has reached epidemic proportions in most of the Westernized world.
Overweightness and obesity adversely impact cardiac structure and function, including on …

The management of cardiovascular diseases (CVD) in patients with obesity presents
numerous challenges. Obesity has a negative effect on almost all of the major CVD risk …

Natriuretic peptides (NPs) are released from the heart in response to pressure and volume
overload. B-type natriuretic peptide (BNP) and N-terminal-proBNP have become important …

Natriuretic peptide (NP) levels (B‐type natriuretic peptide (BNP) and N‐terminal proBNP)
are now widely used in clinical practice and cardiovascular research throughout the world …

The development of cardiac allograft vasculopathy remains the Achilles heel of cardiac
transplantation. Unfortunately, the definitions of cardiac allograft vasculopathy are diverse …

The utility of aminoterminal pro-brain natriuretic peptide (NT-proBNP) testing in the
emergency department to rule out acute congestive heart failure (CHF) and the optimal …